Will Regeneron Help Win the Fight Against COVID-19?

Out of thousands of possible candidates, Regeneron has identified two antibodies with the potential to combat SARS-CoV-2 and combined them into an antibody cocktail called REGN-COV2 to proceed into clinical trials. The company's antibody cocktail is unique in that it can both treat COVID-19 (as a drug would) and prevent healthy individuals from contracting the disease (as a vaccine would), resulting in billions of dollars of savings on healthcare costs if approved.